4/A: Processa Pharmaceuticals Executive Acquires Shares and Warrants
SEC Form 4/A
Patrick Lin, Chief Business Strategy Officer of Processa Pharmaceuticals, reports acquisition of shares and warrants, both directly and indirectly through the Lin Family Trust.
Summary
- Patrick Lin, Chief Business Strategy Officer of Processa Pharmaceuticals, filed a Form 4/A with the SEC.
- The report details changes in beneficial ownership of Processa Pharmaceuticals, Inc. [PCSA] securities.
- On January 29, 2025, Lin acquired warrants exercisable at $0.65 for 43,500 shares of common stock, expiring on January 29, 2030.
- Lin also acquired warrants exercisable at $0.65 for 21,750 shares of common stock, expiring on January 29, 2030.
- These warrants are held indirectly through the Lin Family Trust.
- Lin directly disposed of 29,059 shares of common stock.
- Lin indirectly owns 43,500 shares of common stock through the Lin Family Trust.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard reporting of insider transactions. The acquisition of warrants could be seen as a positive sign of confidence, but the disposal of shares tempers that view.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.
Key Dates
| Date | Description |
|---|---|
| Feb 4, 2024 | Date of Lin Family Trust ownership |
| 01/29/2025 | Date of original filing |
| 01/29/2025 | Transaction date for warrant acquisition |
| 01/29/2030 | Expiration date for warrants |
| 02/17/2025 | Date of earliest transaction |
| 02/18/2025 | Date of signature |
Keywords
Form 4, Beneficial Ownership, Processa Pharmaceuticals, PCSA, Patrick Lin, Warrants, Shares, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.